BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10591631)

  • 21. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M; Nykjaer A; Petersen CM; Cremona O; Pardi R; Andreasen PA; Gliemann J; Christensen EI; Blasi F
    J Cell Biol; 1995 Dec; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase induces receptor mediated brain tumor cell migration and invasion.
    MacDonald TJ; DeClerck YA; Laug WE
    J Neurooncol; 1998 Dec; 40(3):215-26. PubMed ID: 10066093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
    Ghosh S; Brown R; Jones JC; Ellerbroek SM; Stack MS
    J Biol Chem; 2000 Aug; 275(31):23869-76. PubMed ID: 10791952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
    Al-Atrash G; Kitson RP; Xue Y; Mazar AP; Kim MH; Goldfarb RH
    Anticancer Res; 2001; 21(3B):1697-704. PubMed ID: 11497249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.
    Jo M; Thomas KS; Wu L; Gonias SL
    J Biol Chem; 2003 Nov; 278(47):46692-8. PubMed ID: 12963722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
    Tran H; Maurer F; Nagamine Y
    Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent.
    Tuck AB; Hota C; Chambers AF
    Breast Cancer Res Treat; 2001 Dec; 70(3):197-204. PubMed ID: 11804183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor.
    Jo M; Thomas KS; O'Donnell DM; Gonias SL
    J Biol Chem; 2003 Jan; 278(3):1642-6. PubMed ID: 12426305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor.
    Degryse B; Sier CF; Resnati M; Conese M; Blasi F
    FEBS Lett; 2001 Sep; 505(2):249-54. PubMed ID: 11566185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro.
    Webb DJ; Nguyen DH; Sankovic M; Gonias SL
    J Biol Chem; 1999 Mar; 274(11):7412-20. PubMed ID: 10066806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.
    Yebra M; Parry GC; Strömblad S; Mackman N; Rosenberg S; Mueller BM; Cheresh DA
    J Biol Chem; 1996 Nov; 271(46):29393-9. PubMed ID: 8910604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
    J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable antisense RNA expression neutralizes the activity of low-density lipoprotein receptor-related protein and promotes urokinase accumulation in the medium of an astrocytic tumor cell line.
    Hussaini IM; Brown MD; Weaver AM; Carpenter J; Karns LR; Vandenberg SR; Gonias SL
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):183-90. PubMed ID: 10355824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.
    Chavakis T; Kanse SM; Yutzy B; Lijnen HR; Preissner KT
    Blood; 1998 Apr; 91(7):2305-12. PubMed ID: 9516128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and cellular localization of low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in human glioblastoma in vivo.
    Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
    Brain Tumor Pathol; 1998; 15(1):23-30. PubMed ID: 9879460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.